跳至主要内容
临床试验/NCT00773357
NCT00773357已完成2 期

Modeling Stress-precipitated Smoking Behavior for Medication Development

Yale University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2008年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
100
试验地点
1
主要终点
Latency to Initiate Ad-lib Smoking Session

研究概览

简要总结

The purpose of this study is to examine whether guanfacine will attenuate the ability of stress to precipitate smoking lapse behavior in treatment seeking and non-treatment seeking daily smokers.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • ages 18-60
  • able to read and write in English

排除标准

  • any significant current medical conditions that would contraindicate smoking
  • current Diagnostic and Statistical Manual IV (DSM-IV) abuse or dependence of other substances, other than nicotine (or caffeine) dependence
  • positive test result at intake appointments on urine drug screens conducted for opiates, cocaine, or benzodiazepines
  • women who are pregnant or nursing
  • suicidal, homicidal or evidence of severe mental illness
  • participants prescribed any psychotropic drug in the 30 days prior to study enrollment
  • blood donation within the past 6 weeks
  • participants who have engaged in a quit attempt in the past 3 months
  • specific exclusions for administration of guanfacine not already specified include: Hypotensive individuals with sitting blood pressure below 90/50 mmHG; EKG evidence at baseline screening of any clinically significant conduction abnormalities, including a Bazett's corrected QT interval (QTc) >450 msec for men and QTc>470 msec for women; known intolerance for guanfacine

研究组 & 干预措施

Guanfacine

Experimental

guanfacine 3mg/day

干预措施: guanfacine (Drug)

Placebo

Placebo Comparator

placebo control

干预措施: placebo (Drug)

结局指标

主要结局

Latency to Initiate Ad-lib Smoking Session

时间窗: 50 minutes

latency to initiate smoking (in minutes) during a 50-minute period.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sherry McKee

Professor of Psychiatry

Yale University

研究点 (1)

Loading locations...

相似试验